Whole genome sequencing informs cancer therapy

20 February 2011

Although this particular report is not very informative, we are certain to see more and more examples of the use of WGS in clinical settings (as opposed to research studies), to improve characterisation of rare genetic causes of disease, and the specific genetic nature of individual tumours. In many cases this may allow doctors to choose treatments that are more likely to be effective. The feasibility of clinical applications will depend on a range of key issues – currently the subject of a PHG Foundation project - including cost and logistics. 

More from us

Genomics and policy news